ZNF609 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.817600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.623170E-01
Normal-vs-Stage2
1.106820E-01
Normal-vs-Stage3
1.163750E-02
Normal-vs-Stage4
2.030200E-01
Stage1-vs-Stage2
7.284800E-01
Stage1-vs-Stage3
1.387650E-02
Stage1-vs-Stage4
8.046000E-01
Stage2-vs-Stage3
5.184200E-02
Stage2-vs-Stage4
9.495400E-01
Stage3-vs-Stage4
5.304500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.155700E-02
Normal-vs-AfricanAmerican
4.180200E-01
Normal-vs-Asian
2.406400E-01
Caucasian-vs-AfricanAmerican
4.024400E-01
Caucasian-vs-Asian
8.980800E-01
AfricanAmerican-vs-Asian
5.825600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.021500E-02
Normal-vs-Female
7.391500E-02
Male-vs-Female
9.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.026800E-01
Normal-vs-Age(41-60Yrs)
3.362400E-01
Normal-vs-Age(61-80Yrs)
2.413500E-02
Normal-vs-Age(81-100Yrs)
3.712400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.908800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.715400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.805770E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.153200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.731780E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.129840E-01
Normal-vs-Daily Drinker
2.546400E-02
Normal-vs-Weekly Drinker
7.657700E-02
Normal-vs-Occasional Drinker
6.344400E-02
Normal-vs-Social Drinker
1.971600E-01
Non Drinker-vs-Daily Drinker
3.682400E-01
Non Drinker-vs-Weekly Drinker
9.873800E-01
Non Drinker-vs-Occasional Drinker
7.164000E-01
Non Drinker-vs-Social Drinker
3.787800E-01
Daily Drinker-vs-Weekly Drinker
4.122400E-01
Daily Drinker-vs-Occasional Drinker
1.796240E-01
Daily Drinker-vs-Social Drinker
7.776100E-02
Weekly Drinker-vs-Occasional Drinker
7.029800E-01
Weekly Drinker-vs-Social Drinker
3.820000E-01
Occasional Drinker-vs-Social Drinker
5.322200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.401400E-01
Normal-vs-Grade 2
1.760750E-01
Normal-vs-Grade 3
8.227900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.612590E-01
Grade 1-vs-Grade 3
2.944100E-02
Grade 1-vs-Grade 4
4.401400E-01
Grade 2-vs-Grade 3
2.148000E-01
Grade 2-vs-Grade 4
1.760750E-01
Grade 3-vs-Grade 4
8.227900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.935900E-02
Normal-vs-NonDiabetic
6.064300E-02
Diabetic-vs-NonDiabetic
4.476400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.979400E-01
Normal-vs-NoPancreatitis
4.128000E-02
Pancreatitis-vs-NoPancreatitis
7.926500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.331700E-02
Normal-vs-N1
9.349900E-02
N0-vs-N1
1.978160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.434570E-01
Normal-vs-TP53-NonMutant
2.249600E-01
TP53-Mutant-vs-TP53-NonMutant
8.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
